SS
NGNE icon

SBI Securities’s Neurogene NGNE Stock Holding History

SBI Securities’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52K Buy
125
+100
+400% +$1.94K ﹤0.01% 2334
2025
Q4 		$515 Sell
25
-2
-7% -$50 ﹤0.01% 2868
2025
Q3 		$468 Buy
27
+2
+8% +$40 ﹤0.01% 2996
2025
Q2 		$374 Buy
25
+10
+67% +$157 ﹤0.01% 3081
2025
Q1 		$176 Sell
15
-20
-57% -$347 ﹤0.01% 3263
2024
Q4 		$800 Buy
+35
New +$1.3K ﹤0.01% 2712

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

SBI Securities's NGNE Position: Q1 2026 in Review

SBI Securities increased its Neurogene (NGNE) stake by 400% in Q1 2026, buying an estimated $1.94K and bringing the position to 125 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2334.

SBI Securities first reported a position in NGNE in Q4 2024 and has held it in 6 quarters since. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • SBI Securities held 125 shares of Neurogene worth $2.52K as of Q1 2026.
  • SBI Securities bought 100 Neurogene shares in Q1 2026, an estimated $1.94K.
  • Neurogene made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2334 holding.
  • SBI Securities first reported a position in Neurogene in Q4 2024 and has held it in 6 quarters since.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.